First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for de novo Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study

BACKGROUND: The combined use of immune checkpoint inhibitors (ICIs) with palliative chemotherapy (PCT) is a promising first-line treatment for de novo metastatic nasopharyngeal carcinoma (mNPC). However, the efficacy of ICIs with PCT vs PCT with definitive radiation therapy (DRT) remain unclear. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhen-Chong, Liu, Ting, Chen, Yan-Zhou, Guo, Chun-Yan, Liu, Li-Ting, Liu, Sai-Lan, Chen, Qiu-Yan, Mai, Hai-Qiang, Guo, Shan-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Beyond the known - Head and Neck Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445460/
https://www.ncbi.nlm.nih.gov/pubmed/36047451
http://dx.doi.org/10.1177/10732748221124868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445460/
https://www.ncbi.nlm.nih.gov/pubmed/36047451
http://dx.doi.org/10.1177/10732748221124868

Ejemplares similares